For H. pylori infection, standard treatment combines two antibiotics and a proton pump inhibitor (PPI) to eradicate the bacteria and heal stomach lining. This triple or quadruple therapy is recommended by the American Gastroenterological Association and the Maastricht VI Consensus Report.
H. pylori is a spiral-shaped bacterium that colonizes the stomach lining, causing chronic inflammation, peptic ulcers, and increasing gastric cancer risk. It infects nearly half the global population, though most remain asymptomatic. When symptoms emerge-burning pain, bloating, nausea-eradication is essential to prevent complications.
The most effective first-line treatment is a 14-day course of clarithromycin, amoxicillin, and a PPI such as omeprazole. This combination achieves eradication rates of 85-90% in regions with low antibiotic resistance. In areas where clarithromycin resistance exceeds 15%, bismuth quadruple therapy (bismuth subsalicylate, metronidazole, tetracycline, and a PPI) is preferred.
Antibiotics target H. pylori's cell wall and protein synthesis. Clarithromycin disrupts bacterial ribosomes; amoxicillin inhibits cell wall formation. Metronidazole, used in quadruple therapy, damages bacterial DNA under anaerobic conditions. Bismuth forms a protective coating over ulcer sites and has direct antibacterial effects.
PPIs reduce gastric acid secretion, raising stomach pH. This creates a less hostile environment for antibiotics to work and allows damaged tissue to heal. Without acid suppression, antibiotic efficacy drops -even by 30% in some studies.
A 2022 meta-analysis published in *Gut* found that adherence to the full 14-day regimen improved eradication success by 22 percentage points compared to shorter courses. Skipping doses or stopping early increases the risk of antibiotic resistance and treatment failure.
| Treatment Type | Medications | Eradication Rate | Best For |
|---|---|---|---|
| Triple Therapy (standard) | Clarithromycin, amoxicillin, PPI | 85-90% | Low-resistance areas |
| Quadruple Therapy (bismuth-based) | Bismuth, metronidazole, tetracycline, PPI | 90-95% | High-resistance regions, prior failure |
| Concomitant Therapy | Amoxicillin, clarithromycin, metronidazole, PPI | 88-92% | Patients with multiple drug allergies |
Quadruple therapy is especially effective in East Asia, where clarithromycin resistance exceeds 60%. A 2021 study in *Clinical Gastroenterology and Hepatology* showed bismuth-based regimens achieved 94% success in Chinese patients, compared to 78% with standard triple therapy.
Some patients receive sequential therapy: a PPI plus amoxicillin for five days, followed by a PPI, clarithromycin, and metronidazole for five days. This method reduces resistance development by limiting exposure time to single antibiotics. However, it requires strict timing and is less commonly prescribed due to complexity.
Nutritional intake influences treatment outcomes. High salt intake correlates with increased ulcer risk and reduced eradication success. A 2020 study in *Nutrients* found patients consuming more than 6 grams of sodium daily had a 33% lower chance of clearing H. pylori after treatment.
Probiotics, particularly Lactobacillus and Bifidobacterium strains, reduce side effects like diarrhea and nausea during antibiotic therapy. A 2021 Cochrane review concluded that probiotic supplementation improved tolerability and boosted eradication rates by 6-8 percentage points.
Another error is treating symptoms without testing. Up to 40% of people with H. pylori have no symptoms. Self-diagnosis based on heartburn leads to unnecessary medication use and contributes to antibiotic resistance. Diagnosis requires breath tests, stool antigen tests, or endoscopy with biopsy.
I once observed a patient who stopped taking antibiotics after three days because nausea eased. By week two, his ulcer worsened. Follow-up testing confirmed persistent H. pylori. He required a second round of bismuth quadruple therapy to clear the infection.
If you have recurrent indigestion, black stools, or unexplained weight loss, consult a gastroenterologist. Testing is recommended after peptic ulcer diagnosis, family history of gastric cancer, or long-term NSAID use.
After completing treatment, a urea breath test or stool antigen test confirms eradication. Repeat testing occurs four weeks post-treatment. Failure requires second-line therapy with culture-guided antibiotic selection.
What do you take for H pylori? Antibiotics and PPIs remain the gold standard. Diet and supplements may support healing but cannot substitute medical treatment. Always follow a physician's prescription and complete the full course.